(Q46795480)

25 December 2017

title

Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients. (English)

1 reference

25 December 2017

author

Luigi Caimi

6

1 reference

25 December 2017

author name string

Fabio Malacarne

1

1 reference

25 December 2017

Tiziana Benicchi

2

1 reference

25 December 2017

Lucia Dora Notarangelo

3

1 reference

25 December 2017

Luigi Mori

4

1 reference

25 December 2017

Silvia Parolini

5

1 reference

25 December 2017

Michael Hershfield

7

1 reference

25 December 2017

Luigi Daniele Notarangelo

8

1 reference

25 December 2017

Luisa Imberti

9

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

25 December 2017

European Journal of Immunology

published in

1 reference

25 December 2017

volume

35

1 reference

25 December 2017

page(s)

3376-3386

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

Impaired Germinal Center Maturation in Adenosine Deaminase Deficiency

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Gene therapy for adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Longitudinal survey of lymphocyte subpopulations in the first year of life.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Mechanisms of apoptosis in developing thymocytes as revealed by adenosine deaminase-deficient fetal thymic organ cultures

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Lymphocyte homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Restriction of T-cell receptor repertoires in idiopathic CD4+ lymphocytopenia.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Cytochrome c binding to Apaf-1: the effects of dATP and ionic strength

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

To die or not to die: an overview of apoptosis and its role in disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Apoptosis in the pathogenesis and treatment of disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526248

7 January 2021

Identifiers

DOI

10.1002/EJI.200526248

1 reference

25 December 2017

PubMed ID

16276484

1 reference

25 December 2017